Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Inflammatory Bowel Diseases

Free Subscription 21.04.2020 6 Aliment Pharmacol Ther 1 BMC Gastroenterol 1 Clin Gastroenterol Hepatol 1 Dig Dis Sci 3 Eur J Gastroenterol Hepatol 4 Gastroenterology 5 Gut 6 Inflamm Bowel Dis 2 J Crohns Colitis 1 Lancet Gastroenterol Hepatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. AMIOT A, Filippi J, Abitbol V, Cadiot G, et al
   Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study.
   Aliment Pharmacol Ther. 2020 Apr 14. doi: 10.1111/apt.15717.
   PubMed         Abstract available
   
   
2. PROBERT C
   Commentary: vitamin D supplementation in Crohn's disease.
   Aliment Pharmacol Ther. 2020;51:201-202.
   PubMed        
   
   
3. TOWNSEND T, Subramanian S
   Editorial: endoscopic inflammation in ileoanal pouches-does it really matter?
   Aliment Pharmacol Ther. 2020;51:170-171.
   PubMed        
   
   
4. BENSON-POPE SJ, Gearry RB
   Editorial: better outcomes for Crohn's disease-more than just the drugs?
   Aliment Pharmacol Ther. 2020;51:167-168.
   PubMed        
   
   
5. HART A
   Commentary: safety of anti-TNF use in pregnancy.
   Aliment Pharmacol Ther. 2020;51:205-206.
   PubMed        
   
   
6. KAYAL M, Ungaro R
   Editorial: endoscopic inflammation in ileoanal pouches-does it really matter? Authors' reply.
   Aliment Pharmacol Ther. 2020;51:172.
   PubMed        
   
   

   
   BMC Gastroenterol

7. ALLNER C, Melde M, Becker E, Fuchs F, et al
   Baseline levels of dynamic CD4(+) T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.
   BMC Gastroenterol. 2020;20:103.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

8. ALLOCCA M, Fiorino G, Furfaro F, Gilardi D, et al
   Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic.
   Clin Gastroenterol Hepatol. 2020 Apr 15. pii: S1542-3565(20)30524.
   PubMed        
   
   

   
   Dig Dis Sci

9. COBURN ES, Siegel CA, Winter M, Shah ED, et al
   Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
   Dig Dis Sci. 2020 Apr 16. pii: 10.1007/s10620-020-06252.
   PubMed         Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

10. LI Q, Zhang T, Ding X, Xiang L, et al
    Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis.
    Eur J Gastroenterol Hepatol. 2020 Apr 10. doi: 10.1097/MEG.0000000000001725.
    PubMed         Abstract available
    
    
11. BARDASI G, Romagnoli A, Foschini MP, Mantovani A, et al
    Pyostomatitis vegetans in a pediatric patient with ulcerative colitis: case report of a rare pediatric inflammatory bowel disease extraintestinal manifestation and review of the literature.
    Eur J Gastroenterol Hepatol. 2020 Apr 10. doi: 10.1097/MEG.0000000000001723.
    PubMed         Abstract available
    
    
12. BERTANI L, Mumolo MG, Tapete G, Albano E, et al
    Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment.
    Eur J Gastroenterol Hepatol. 2020 Apr 8. doi: 10.1097/MEG.0000000000001731.
    PubMed         Abstract available
    
    

    
    Gastroenterology

13. MACALUSO FS, Castiglione F, Rispo A, Orlando A, et al
    The VERSIFY Trial: What About Ultrasound Assessment?
    Gastroenterology. 2020;158:1176-1177.
    PubMed        
    
    
14. DANESE S, Rimola J, Siegelman J
    Reply.
    Gastroenterology. 2020;158:1177-1178.
    PubMed        
    
    
15. RUBIN DT, Feuerstein JD, Wang AY, Cohen RD, et al
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
    Gastroenterology. 2020 Apr 10. pii: S0016-5085(20)30482.
    PubMed         Abstract available
    
    
16. HOLMER AK, Dulai PS
    Deep Learning Accurately Predicts Endoscopic and Histologic Remission in Ulcerative Colitis - What the Eye Doesn't See, the Artificial Mind Does Actually Know.
    Gastroenterology. 2020 Apr 11. pii: S0016-5085(20)30481.
    PubMed        
    
    

    
    Gut

17. SOKOL H, Brot L, Stefanescu C, Auzolle C, et al
    Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease.
    Gut. 2020;69:462-472.
    PubMed         Abstract available
    
    
18. OLEN O, Askling J, Sachs MC, Neovius M, et al
    Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014.
    Gut. 2020;69:453-461.
    PubMed         Abstract available
    
    
19. VAN DER GIESSEN J, Binyamin D, Belogolovski A, Frishman S, et al
    Modulation of cytokine patterns and microbiome during pregnancy in IBD.
    Gut. 2020;69:473-486.
    PubMed         Abstract available
    
    
20. POWELL N, Pantazi E, Pavlidis P, Tsakmaki A, et al
    Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells.
    Gut. 2020;69:578-590.
    PubMed         Abstract available
    
    
21. KENNEDY NA, Jones GR, Lamb CA, Appleby R, et al
    British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
    Gut. 2020 Apr 17. pii: gutjnl-2020-321244. doi: 10.1136/gutjnl-2020-321244.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

22. BERNSTEIN CN
    Is Antibiotic Use a Cause of IBD Worldwide?
    Inflamm Bowel Dis. 2020;26:448-449.
    PubMed        
    
    
23. LEE TW
    Editorial: Risk of Cancer Development in IBD-Inflammation vs Immunosuppression.
    Inflamm Bowel Dis. 2020;26:460-461.
    PubMed        
    
    
24. 
    DPP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Apr 16. pii: 5820737. doi: 10.1093.
    PubMed        
    
    
25. 
    Corrigendum to: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822087. doi: 10.1093.
    PubMed        
    
    
26. LINHARES M, Ramos D, Pereira F, Azevedo R, et al
    Hidradenitis Suppurativa and Crohn Disease: A Rare Association.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822088. doi: 10.1093.
    PubMed        
    
    
27. DERER S, Brethack AK, Pietsch C, Jendrek ST, et al
    Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822108. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

28. PEYRIN-BIROULET C, D'Amico F, Peyrin-Biroulet L
    Will COVID-19 infection be less severe in ulcerative colitis than in Crohn's patients due to a lower rate of smokers?
    J Crohns Colitis. 2020 Apr 18. pii: 5821493. doi: 10.1093.
    PubMed        
    
    
29. HONAP S, Chee D, Chapman TP, Patel M, et al
    Real-World Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multi-Centre UK Experience.
    J Crohns Colitis. 2020 Apr 13. pii: 5819381. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

30. MAO R, Liang J, Shen J, Ghosh S, et al
    Implications of COVID-19 for patients with pre-existing digestive diseases.
    Lancet Gastroenterol Hepatol. 2020 Mar 11. pii: S2468-1253(20)30076.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: